Back to main page

DREAM Module Identification Challenge – Consensus modules

PPI-STRING_Consensus_mod76

Assigned name NA
Network PPI-STRING
Module ID PPI-STRING_Consensus_mod76
Module size 22 genes

Module genes

This module comprises the following genes:

Gene ID Gene Symbol Gene Name
8708

B3GALT1 beta-1,3-galactosyltransferase 1
8707

B3GALT2 beta-1,3-galactosyltransferase 2
10317

B3GALT5 beta-1,3-galactosyltransferase 5
10678

B3GNT1 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2
2683

B4GALT1 beta-1,4-galactosyltransferase 1
8704

B4GALT2 beta-1,4-galactosyltransferase 2
8703

B4GALT3 beta-1,4-galactosyltransferase 3
8702

B4GALT4 beta-1,4-galactosyltransferase 4
2523

FUT1 fucosyltransferase 1 (H blood group)
2524

FUT2 fucosyltransferase 2
2525

FUT3 fucosyltransferase 3 (Lewis blood group)
2526

FUT4 fucosyltransferase 4
2527

FUT5 fucosyltransferase 5
2528

FUT6 fucosyltransferase 6
2529

FUT7 fucosyltransferase 7
10690

FUT9 fucosyltransferase 9
2651

GCNT2 glucosaminyl (N-acetyl) transferase 2 (I blood group)
120071

GYLTL1B LARGE xylosyl- and glucuronyltransferase 2
9215

LARGE LARGE xylosyl- and glucuronyltransferase 1
10402

ST3GAL6 ST3 beta-galactoside alpha-2,3-sialyltransferase 6
84620

ST6GAL2 ST6 beta-galactoside alpha-2,6-sialyltransferase 2
6489

ST8SIA1 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1

Functional annotation

Modules were tested for enrichment in functional and pathway annotations using two complementary approaches:
1. To select a small number of specific / non-redundant annotations for each module, a regression-based approach was used;
2. To obtain the complete set of enriched annotations, an extension of Fisher’s exact test that takes annotation bias into account was employed (Wallenius’ non-central hypergeometric distribution).

Most specific annotations for this module

Coeff.1P-value.2Source.3Term.4Class.5
4.64e-01 3.62e-24 GO fucosyltransferase activity

molecular_function
2.51e-01 7.46e-11 GO beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity

molecular_function
1.67e-01 6.64e-23 GO fucosylation

biological_process
1.18e-01 1.86e-12 GO oligosaccharide biosynthetic process

biological_process
3.87e-02 4.17e-35 GO protein glycosylation

biological_process
2.07e-03 4.15e-07 GO UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity

molecular_function

1Regression coefficient

2Fisher’s exact test nominal P-value

3Annotation source (Reactome, GO biological process (BP), molecular function (MF) and cellular component (CC))

4GO category or Reactome pathway

5High-level branch of annotation tree

Gene membership

All enriched annotations

Gene Ontology

P-value1 FDR2 Term
0.00e+00 0.00e+00 protein glycosylation

0.00e+00 0.00e+00 glycosylation

0.00e+00 0.00e+00 glycoprotein biosynthetic process

0.00e+00 0.00e+00 glycoprotein metabolic process

0.00e+00 0.00e+00 macromolecule glycosylation

0.00e+00 0.00e+00 carbohydrate metabolic process

0.00e+00 0.00e+00 fucosylation

0.00e+00 0.00e+00 L-fucose catabolic process

0.00e+00 0.00e+00 fucose metabolic process

0.00e+00 0.00e+00 Golgi cisterna membrane

0.00e+00 0.00e+00 Golgi membrane

0.00e+00 0.00e+00 Golgi cisterna

0.00e+00 0.00e+00 Golgi stack

0.00e+00 0.00e+00 transferase activity, transferring glycosyl groups

0.00e+00 0.00e+00 transferase activity, transferring hexosyl groups

0.00e+00 0.00e+00 UDP-galactosyltransferase activity

0.00e+00 0.00e+00 galactosyltransferase activity

0.00e+00 0.00e+00 fucosyltransferase activity

0.00e+00 0.00e+00 alpha-(1->3)-fucosyltransferase activity

1.35e-11 8.87e-09 N-acetyllactosamine synthase activity


11Nominal enrichment p-value (Wallenius’ noncentral hypergeometric distribution)

2FDR corrected p-value (Benjamini-Hochberg)

Reactome

P-value1 FDR2 Term
0.00e+00 0.00e+00 KERATAN SULFATE BIOSYNTHESIS
3.08e-12 1.20e-09 KERATAN SULFATE BIOSYNTHESIS
7.76e-12 2.27e-09 KERATAN SULFATE KERATIN METABOLISM
3.22e-11 1.21e-08 KERATAN SULFATE KERATIN METABOLISM
9.69e-09 2.14e-06 GLYCOSAMINOGLYCAN METABOLISM
1.34e-08 3.86e-06 N GLYCAN ANTENNAE ELONGATION
1.49e-08 4.27e-06 GLYCOSAMINOGLYCAN METABOLISM
2.33e-08 6.55e-06 N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI
5.30e-08 1.07e-05 N GLYCAN ANTENNAE ELONGATION
8.47e-08 1.67e-05 METABOLISM OF CARBOHYDRATES
9.40e-08 1.84e-05 N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI
1.76e-07 4.43e-05 TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION
4.43e-07 1.05e-04 METABOLISM OF CARBOHYDRATES
1.65e-06 2.77e-04 TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION
1.67e-06 3.61e-04 ASPARAGINE N LINKED GLYCOSYLATION
8.34e-06 1.26e-03 ASPARAGINE N LINKED GLYCOSYLATION
1.89e-05 2.71e-03 POST TRANSLATIONAL PROTEIN MODIFICATION
5.26e-05 8.74e-03 POST TRANSLATIONAL PROTEIN MODIFICATION
4.78e-04 6.18e-02 PRE NOTCH PROCESSING IN GOLGI
1.42e-03 1.37e-01 PRE NOTCH PROCESSING IN GOLGI

11Nominal enrichment p-value (Wallenius’ noncentral hypergeometric distribution)

2FDR corrected p-value (Benjamini-Hochberg)

Mouse mutant phenotypes

P-value1 FDR2 Term
1.43e-05 5.98e-02 abnormal leukocyte tethering or rolling

5.88e-05 1.59e-01 impaired neutrophil recruitment

4.02e-03 1.00e+00 abnormal leukocyte physiology

4.05e-03 1.00e+00 decreased susceptibility to type IV hypersensitivity reaction

5.37e-03 1.00e+00 increased circulating creatinine level

5.61e-03 1.00e+00 abnormal nervous system regeneration

5.63e-03 1.00e+00 dystocia

9.37e-03 1.00e+00 disorganized retinal outer plexiform layer

9.37e-03 1.00e+00 vitreal fibroplasia

9.37e-03 1.00e+00 abnormal pulmonary alveolar system morphology

1.12e-02 1.00e+00 abnormal cerebellar lobule formation

1.12e-02 1.00e+00 abnormal granulocyte physiology

1.12e-02 1.00e+00 decreased coping response

1.12e-02 1.00e+00 skeletal muscle endomysial fibrosis

1.12e-02 1.00e+00 disorganized retinal ganglion layer

1.49e-02 1.00e+00 thin retinal outer plexiform layer

1.50e-02 1.00e+00 skeletal muscle fiber degeneration

1.50e-02 1.00e+00 skeletal muscle degeneration

1.50e-02 1.00e+00 abnormal retinal outer plexiform layer morphology

1.50e-02 1.00e+00 vitreous body deposition


11Nominal enrichment p-value (Wallenius’ noncentral hypergeometric distribution)

2FDR corrected p-value (Benjamini-Hochberg)


Generated on: Thu Aug 30 17:23:27 2018 - R2HTML